Comparison of Cardiovascular Risk Scores Performances in a Contemporary Mixed-Ancestry Systemic Lupus Erythematosus Population
- PMID: 40536904
- DOI: 10.1097/RHU.0000000000002250
Comparison of Cardiovascular Risk Scores Performances in a Contemporary Mixed-Ancestry Systemic Lupus Erythematosus Population
Abstract
Objective: Cardiovascular disease (CVD) remains the leading cause of mortality in systemic lupus erythematosus (SLE). This study compared the performance of SLE Cardiovascular Risk Equation (SLECRE), Framingham Risk Score (FRS), modified Framingham Risk Score (mFRS), and QRISK3 in estimating CVD risk in a recent and mixed ancestry population of SLE patients (2009-2021). Additionally, a simpler model, the Easy Atherosclerosis Risk Assessment for SLE (EASLE), was proposed.
Methods: A historical analysis of 550 SLE patients with 10-year follow-up in a tertiary hospital was conducted. Traditional and SLE-specific risk factors for CVD were obtained through electronic medical records (2009-2011), and the incidence of cardiovascular (CV) events over the subsequent 10 years (2019-2021) was evaluated. Variables associated with CV events were included in the multiple logistic regression to develop the EASLE. The performances of SLECRE, FRS, mFRS, QRISK3, and EASLE were assessed and compared. Multiple logistic regression was used to develop the EASLE.
Results: Among 550 patients, 34 CVD events were observed (6.2%). Sensitivity and specificity were, respectively, 17.6% and 94.4% in FRS, 58.8% and 84.9% in mFRS, 38.2% and 86.4% in QRISK3, and 91.2% and 22.3% in SLECRE. The areas under the curve were 0.708 for both FRS and mFRS, 0.703 for QRISK3, and 0.553 for SLECRE. The mFRS had the highest balanced accuracy (71.9%). EASLE, with only 3 variables (age, smoking status, and antihypertensive treatment) had 55.9% sensitivity, 86.8% specificity, 71.3% balanced accuracy, and an area under the curve of 0.752.
Conclusions: The mFRS and EASLE exhibited comparable performances and highest balanced accuracies in a recent mixed-ancestry SLE population. EASLE, a simplified tool, offers a promising tool for CVD risk assessment in SLE patients, especially in resource-limited settings.
Keywords: Framingham Risk Score; assessment; atherosclerosis; cardiovascular risk; systemic lupus erythematosus (SLE).
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus.Semin Arthritis Rheum. 2024 Aug;67:152468. doi: 10.1016/j.semarthrit.2024.152468. Epub 2024 May 17. Semin Arthritis Rheum. 2024. PMID: 38788567 Free PMC article.
-
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.Lupus Sci Med. 2021 May;8(1):e000448. doi: 10.1136/lupus-2020-000448. Lupus Sci Med. 2021. PMID: 34045359 Free PMC article.
-
Performance of SCORE2, QRISK3 and PREVENT equations in systemic lupus erythematosus.Lupus. 2025 Sep;34(10):1057-1060. doi: 10.1177/09612033251356138. Epub 2025 Jul 1. Lupus. 2025. PMID: 40590211
-
Comparative efficacy and safety of different recommended doses of telitacicept in patients with systemic lupus erythematosus in China: a systematic review and meta-analysis.Front Immunol. 2025 Jan 10;15:1472292. doi: 10.3389/fimmu.2024.1472292. eCollection 2024. Front Immunol. 2025. PMID: 39867893 Free PMC article.
-
Serum lipid profile in systemic lupus erythematosus.Front Immunol. 2025 Jan 14;15:1503434. doi: 10.3389/fimmu.2024.1503434. eCollection 2024. Front Immunol. 2025. PMID: 39877363 Free PMC article.
References
-
- World Health Organization. Global health estimates 2019: deaths by cause, age, sex, by country and by region, 2000–2019. 2020. Available at: https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.... Accessed 26 November, 2023.
-
- England BR, Thiele GM, Anderson DR, et al. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036.
-
- Bruce IN, Urowitz MB, Gladman DD, et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum. 2003;48:3159–3167.
-
- Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997;145:408–415.
-
- Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44:2331–2337.
LinkOut - more resources
Full Text Sources